市场调查报告书
商品编码
1423586
2030 年果冻市场预测:按产品类型、手术、应用、最终用户和地区进行的全球分析Microsurgery Market Forecasts to 2030 - Global Analysis By Product Type (Operating Microscopes, Microsurgery Needle Holder, Micro Forceps, Micro Sutures and Other Product Types), Procedure, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球果冻市场规模为 22.4 亿美元,预计预测期内复合年增长率为 7.2%,到 2030 年将达到 36.5 亿美元。
果冻是一种高度专业化的外科手术,使用精緻的缝线、显微镜等放大设备和精密仪器对极小的身体部位进行手术。外科医生经常对肉眼看不见的微小解剖特征进行复杂的手术,例如脆弱的组织、血管和神经。此外,果冻技术的精确性需要执行这些技术的外科医师经过特殊的训练和能力。这些技术包括使用超细针和缝合线进行精确缝合、对细节的仔细关注以及精细的组织操作。
根据美国国家医学图书馆2021年6月发表的研究结果,在放大镜下进行牙根覆盖的果冻技术优于传统果冻技术,可减少牙龈厚度和患者满意度。发现果冻部位癒合得更快。
慢性病增加
心血管疾病、糖尿病、癌症和神经系统疾病等慢性疾病通常需要复杂且精确的手术介入。果冻在这些疾病的治疗中发挥重要作用。显微果冻手术可以减少创伤、缩短恢復时间并改善患者的治疗效果。果冻市场受益于患者和外科医生对微创手术的日益偏好。
将新的果冻技术整合到现有的医疗保健系统中
将新的果冻技术纳入现有的医疗保健系统需要大量的规划和实施。这些技术必须与目前的基础设施集成,例如手术室、电子健康记录(EHR) 系统和其他手术设备。这种复杂性会导致实施阶段的延误和额外成本。此外,不同技术和软体平台之间可能会出现相容性问题,导致效率低下和资料管理挑战,从而阻碍市场成长。
外科手术技术不断进步
技术的发展显着提高了果冻手术的精确度和可视性,特别是在手术显微镜、显像模式和仪器方面。材料科学领域的不断发展正在创造可改善手术效果的特定仪器和材料。例如,由现代合金和复合材料製成的显微外科器械更俱生物相容性、耐用性和精确性,所有这些都提高了治疗过程中的有效性。
高成本
与专业果冻设备、仪器和培训相关的巨额成本可能会限制果冻的普及。较小的医疗机构,特别是在资源匮乏地区和发展中国家,可能难以承担初始投资和持续成本,从而限制了这些地区果冻服务的可用性。事实确实如此。这种负担可能会限制果冻领域发展的资金分配和最尖端科技的投资,从而影响医疗保健的整体品质。
COVID-19 的影响
COVID-19 大流行对果冻市场产生了重大影响,在各方面造成了干扰。由于医疗机构优先分配资源来应对这一流行病,选择性果冻手术显着减少,导致手术延迟和患者数量减少。由于製造限制和物流挑战,供应链中断影响了专用果冻器械和手术显微镜的可得性。严格的安全通讯协定和手术期间使用个人防护设备(PPE) 成为强制性要求,影响了手术的工作流程。
手术显微镜领域预计将成为预测期内最大的市场
由于光学元件、高解析度相机和照明系统等可实现放大和扩大视野的功能,显微果冻中使用的手术显微镜预计将出现良好的增长。这些显微镜为医生提供了手术部位清晰、完整的视图,从而实现精确、系统化的手术。这些显微镜广泛用于医疗领域,包括妇科、泌尿系统、神经科、眼科、整形外科、骨科和耳鼻喉科。这有利于市场拓展。
神经果冻领域预计在预测期内复合年增长率最高。
果冻果冻领域预计在预测期内复合年增长率最高,因为它涵盖了影响大脑、脊髓、神经及其周围组织的各种手术。在此类手术中,具有先进光学元件、高放大倍率和照明功能的高品质手术显微镜对于观察和处理小型神经结构至关重要。这些显微镜提高了神经外科医生的视力,使他们能够精确地进行复杂的手术。
由于其高度发达的医疗保健系统、高感染疾病率、众多大型国家临床实验室以及方便获得最尖端科技,北美在预测期内占据最大的市场占有率。此外,由于患者群体扩大、社会意识提高以及外科医生使用手术显微镜的监管核准,对感染疾病诊断套件的需求不断增加,也推动了该地区的市场成长。
预计亚太地区在预测期内的复合年增长率最高。这是由于老年人口数量不断增加,他们更有可能遇到与慢性病相关的问题。由于行业巨头缺乏创新,独立的新业务正在进入市场,提供高品质且价格合理的产品,增加可支配收入并扩大医疗保健的覆盖范围,正在推动市场成长。
According to Stratistics MRC, the Global Microsurgery Market is accounted for $2.24 billion in 2023 and is expected to reach $3.65 billion by 2030 growing at a CAGR of 7.2% during the forecast period. Microsurgery is a highly specialized surgical procedure that uses delicate sutures, magnifying equipment such as microscopes, and precise instruments to operate on minuscule bodily components. Surgeons may carry out complex operations on fragile tissues, blood vessels, nerves, and other microscopic anatomical features that are sometimes invisible to the unaided eye. Moreover, the precise nature of microsurgery techniques needs particular training and abilities for surgeons conducting them. Techniques include precision suturing using ultra-fine needles and sutures, careful attention to detail, and sensitive tissue manipulation.
According to a research study published by the National Library of Medicine in June 2021, under magnification, the microsurgical method for root coverage was found to be superior to the traditional microsurgical approach, and in addition to enhanced gingival thickness and patient satisfaction ratings, neovascularization at the microsurgical sites healed more quickly.
Rising prevalence of chronic diseases
Chronic diseases such as cardiovascular disorders, diabetes, cancer, and neurological conditions often necessitate complex and precise surgical interventions. Microsurgery plays a crucial role in treating these conditions. Minimally invasive surgeries, facilitated by microsurgical techniques and instruments, offer reduced trauma, quicker recovery times, and improved patient outcomes. The market for microsurgery benefits from this trend as it aligns with the increasing preference for less invasive approaches among patients and surgeons.
Integrating new microsurgical technologies into existing healthcare systems
Incorporating new microsurgical technologies into existing healthcare systems requires significant planning and execution. It involves integrating these technologies with the current infrastructure, including operating rooms, electronic health records (EHR) systems, and other surgical equipment. This complexity can lead to delays and additional expenses during the implementation phase. Moreover, compatibility issues between different technologies or software platforms may arise, leading to inefficiencies and data management challenges hamper the growth of the market.
Growing technological advances in surgical procedures
Technological developments have greatly enhanced precision and visibility during microsurgical procedures, especially with regard to operating microscopes, imaging modalities, and instruments. Continuous developments in the field of materials science have resulted in the creation of specific tools and materials that enhance surgical results. Microsurgical instruments composed of modern alloys or composite materials, for example, have improved biocompatibility, endurance, and accuracy, all of which boost their effectiveness during treatments.
High cost
The significant expenses related to specialized microsurgical equipment, instruments, and training can limit accessibility to microsurgery. Smaller healthcare facilities, especially in resource-constrained regions or developing countries, may struggle to afford the initial investment and ongoing costs, leading to limited availability of microsurgical services in these areas. This strain may limit the allocation of funds for the development of microsurgical departments or investment in cutting-edge technologies, impacting overall healthcare quality.
Covid-19 Impact
The COVID-19 pandemic significantly impacted the microsurgery market, causing disruptions across various fronts. Elective microsurgical procedures experienced a substantial decline as healthcare facilities prioritized resources for pandemic response, leading to postponed surgeries and reduced patient volumes. Supply chain disruptions affected the availability of specialized microsurgical instruments and operating microscopes due to manufacturing constraints and logistical challenges. Stringent safety protocols and increased utilization of personal protective equipment (PPE) during surgeries became imperative, influencing procedural workflows.
The operating microscopes segment is expected to be the largest during the forecast period
Operating microscopes used in microsurgery are expected to have a lucrative growth due to characteristics such as enhanced optics, high-resolution cameras, and illumination systems that provide magnification and increased vision. They give doctors clear, thorough views of the surgical site, enabling them to perform precise, systematic procedures. These microscopes are used in a wide range of medical specialties, such as gynecology, urology, neurology, ophthalmology, plastic surgery, orthopedics, and ENT. This promotes market expansion.
The neurological microsurgeries segment is expected to have the highest CAGR during the forecast period
The neurological microsurgeries segment is anticipated to witness the highest CAGR growth during the forecast period, as a broad variety of operations affecting the brain, spinal cord, nerves, and surrounding tissues are included in the field of neurological microsurgery. For these operations, high-quality operating microscopes with sophisticated optics, strong magnification, and lighting capabilities are crucial for seeing and working with small neurological structures. These microscopes improve sight for neurosurgeons, allowing them to precisely execute complex surgery.
North America is projected to hold the largest market share during the forecast period because of its highly developed healthcare system, high incidence of infectious illnesses, numerous big national clinical labs, and convenient access to cutting-edge technology. Moreover due to the increased demand for infectious disease diagnostic kits brought on by an expanding patient pool and growing public awareness and approval from regulatory bodies for the use of surgical microscopes by surgeons is also responsible for driving the market's growth in the region.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the surge is attributed to an increase in the senior population, who are more likely to experience issues related to chronic illnesses. Due to the lack of innovation from the industry's major players, new, independent businesses have entered the market and are offering high-quality, reasonably priced items thus rising disposable income, and expanding access to healthcare encourage the growth of the market
Key players in the market
Some of the key players profiled in the Microsurgery Market include Scanlan International, Olympus Corp., HAAG-STREIT GROUP, Accurate Surgical & Scientific Instruments Corp., Surtex Instruments Ltd., KLS Martin Group, Topcon Corp., Integra LifeSciences, B. Braun Melsungen Inc., Leica Microsystems, Carl Zeiss AG, Medtronic, Novartis AG, Baxter, Halma PLC, Peter LAZIC GmbH, Danaher, SYNOVIS MICRO COMPANIES ALLIANCE and AROSurgical Instruments
In December 2023, Integra LifeSciences Announces Definitive Agreement To Acquire Acclarent®. The acquisition will become part of Integra's Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the neurosurgery segment.
In November 2023, Medtronic announces FDA approval of minimally invasive device to treat hypertension. With this approval, Medtronic will immediately begin commercialization.
In May 2023, Medtronic to acquire wearable insulin patch maker EOFlow, this acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support.